Diabetes mellitus, type 1 Trials in Neuss, Germany
Conditions / Diabetes mellitus, type 1 / Neuss, Germany
Diabetes mellitus, type 1 has been the subject of sustained clinical investigation across multiple research sites.
67 total trials for this combination
Showing top 10 of 67 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00312104 | Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 Diabetes | COMPLETED | PHASE3 |
| NCT06945406 | A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes | RECRUITING | PHASE1 |
| NCT02220296 | A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0123-0338 in Healthy Subjects and in Subjects With Type 1 Diabetes Mellitus | COMPLETED | PHASE1 |
| NCT01680328 | Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume Combinations | COMPLETED | PHASE1 |
| NCT02627287 | A Comparative Trial Focusing on Injections With the Medical Device DV3316 Pen-injector Versus FlexPen® | COMPLETED | PHASE1 |
| NCT01865279 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Formulation of Insulin Degludec | COMPLETED | PHASE1 |
| NCT01865305 | Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With Diabetes | COMPLETED | PHASE1 |
| NCT01865292 | Comparing the Pharmacodynamics and Pharmacokinetics of Explorative Formulation of Insulin Degludec With Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes | COMPLETED | PHASE1 |
| NCT01028404 | A Two Part Trial Investigating NN1952 in Healthy Subjects and Subjects With Type 1 and Type 2 Diabetes | COMPLETED | PHASE1 |
| NCT01730014 | A Trial Investigating the Safety, Tolerability, and Distribution and Activity in the Body of NNC0148-0000-0287 Injected Under the Skin in Healthy Subjects and in Subjects With Type 1 Diabetes | COMPLETED | PHASE1 |